Table 3.
Minimal Pain Reduction of 30% and 50%
| Population | Phenytoin | Placebo |
|---|---|---|
| MPR50 N (%) | MPR50 N (%) | |
| All patients (N = 12) | 4 (33) | 1 (8) |
| Responders (N = 6) | 4 (67) | 1 (17) |
| MPR30 N (%) | MPR30 N (%) | |
| All patients (N = 12) | 6 (50) | 3 (25) |
| Responders (N = 6) | 6 (100) | 3 (50) |
Abbreviations: MPR30, minimal pain reduction of ≥30%; MPR50, minimal pain reduction of ≥50%; N, number of patients.